Cognitive evaluation
Cognitive evaluation is an intervention with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of BDNF Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease
Cognitive Abilities in Brain Damaged Patients
Cognitive and Psychiatric Effects of Linaclotide on Patients With Constipation
ATtention Test and Executive Functions After STroke to Predict Depression.
Evaluation and Neural Basis of Communication in Patients With Multiple Sclerosis
Clinical Trials (8)
Study of BDNF Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease
Cognitive Abilities in Brain Damaged Patients
Cognitive and Psychiatric Effects of Linaclotide on Patients With Constipation
ATtention Test and Executive Functions After STroke to Predict Depression.
Evaluation and Neural Basis of Communication in Patients With Multiple Sclerosis
Emotional Processing, Family Life, Friendship and Social Integration in Patients With Multiple Sclerosis
Neuropsychological Evaluation for Early Diagnosis of PSP
Validation of Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS)
All 8 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 8